IQVIA Holdingsvs.West Pharmaceutical Services
IQV vs WST · both in CDMO & pharma manufacturing, part of the Medicine, pharma & life science value chain: Contract development and manufacturing of medicines, the industrial backbone behind the drugs.
IQVIA Holdings is about 1.6× larger than West Pharmaceutical Services by market cap; IQVIA Holdings trades at the lower P/E (31.4 vs 47.0); year to date, West Pharmaceutical Services leads (+32.0% vs +14.8%).
Side by side
| IQV | WST | |
|---|---|---|
| Market cap | $43.2B | $26.6B |
| Price | $259.88 | $366.00 |
| Today | +0.4% | +0.8% |
| Return YTD | +14.8% | +32.0% |
| Return 1Y | +29.1% | +35.6% |
| Since June 26, 2026 | +36.0% | +4.3% |
| P/E | 31.4 | 47.0 |
| P/S | 2.5 | 8.0 |
| P/B | 7.0 | 8.9 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
IQVIA HoldingsIQV
Drug companies outsource clinical trials to IQVIA, and many of the same customers buy its health data and analytics. A third arm sells commercial services to the pharmaceutical industry.
Full IQV profile →West Pharmaceutical ServicesWST
Stoppers, syringe components and the rest of the packaging that goes around an injectable drug. West also builds the injection and delivery systems themselves, including for biologics.
Full WST profile →More IQV & WST comparisons
Other head-to-heads in the CDMO & pharma manufacturing segment.